مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma.
Normal view MARC view ISBD view

Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma. [electronic resource]

By:
  • Thomas, Alissa A
Contributor(s):
  • Fisher, Jan L
  • Hampton, Thomas H
  • Christensen, Brock C
  • Tsongalis, Gregory J
  • Rahme, Gilbert J
  • Whipple, Chery A
  • Steel, Sandra E
  • Davis, Melissa C
  • Gaur, Arti B
  • Lewis, Lionel D
  • Ernstoff, Marc S
  • Fadul, Camilo E
Producer: 20170920Description: 379-389 p. digitalISSN:
  • 1432-0851
Subject(s):
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
  • Bevacizumab -- administration & dosage
  • Brain Neoplasms -- blood
  • Chemoradiotherapy
  • Cytokines -- blood
  • Dacarbazine -- administration & dosage
  • Disease-Free Survival
  • Female
  • Glioblastoma -- blood
  • Humans
  • Immunotherapy -- methods
  • Leukocytes, Mononuclear -- drug effects
  • Male
  • Middle Aged
  • T-Lymphocytes, Regulatory -- drug effects
  • Temozolomide
  • Vascular Endothelial Growth Factor A -- antagonists & inhibitors
Online resources:
  • Available from publisher's website
In: Cancer immunology, immunotherapy : CII vol. 66
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Log in to your account to post a comment.

Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma.

APA

Thomas A. A., Fisher J. L., Hampton T. H., Christensen B. C., Tsongalis G. J., Rahme G. J., Whipple C. A., Steel S. E., Davis M. C., Gaur A. B., Lewis L. D., Ernstoff M. S. & Fadul C. E. (20170920). Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma. : Cancer immunology, immunotherapy : CII.

Chicago

Thomas Alissa A, Fisher Jan L, Hampton Thomas H, Christensen Brock C, Tsongalis Gregory J, Rahme Gilbert J, Whipple Chery A, Steel Sandra E, Davis Melissa C, Gaur Arti B, Lewis Lionel D, Ernstoff Marc S and Fadul Camilo E. 20170920. Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma. : Cancer immunology, immunotherapy : CII.

Harvard

Thomas A. A., Fisher J. L., Hampton T. H., Christensen B. C., Tsongalis G. J., Rahme G. J., Whipple C. A., Steel S. E., Davis M. C., Gaur A. B., Lewis L. D., Ernstoff M. S. and Fadul C. E. (20170920). Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma. : Cancer immunology, immunotherapy : CII.

MLA

Thomas Alissa A, Fisher Jan L, Hampton Thomas H, Christensen Brock C, Tsongalis Gregory J, Rahme Gilbert J, Whipple Chery A, Steel Sandra E, Davis Melissa C, Gaur Arti B, Lewis Lionel D, Ernstoff Marc S and Fadul Camilo E. Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma. : Cancer immunology, immunotherapy : CII. 20170920.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site